Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

Detalles Bibliográficos
Autores principales: Caocci, Giovanni, La Nasa, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220809/
https://www.ncbi.nlm.nih.gov/pubmed/32405693
http://dx.doi.org/10.1007/s00277-020-04067-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220809/
https://www.ncbi.nlm.nih.gov/pubmed/32405693
http://dx.doi.org/10.1007/s00277-020-04067-6

Ejemplares similares